Leqembi: What you should know about the Alzheimer’s drug
Leqembi, a drug that inhibits the disease-causing mechanism of Alzheimer's, has now also been approved in the EU. We answer...
Read moreDetailsLatest Post
Why we like to avoid diagnoses – and how we can prepare ourselves
A recent study from Berlin shows that a third of people don't even want to know certain diagnoses. The consequences...
Read moreDetails
Saving at the wrong end: Why cuts to dementia and family support are fatal
Care will increasingly have to take place at home. Cuts in support for those affected and their family carers are...
Read moreDetails
Brain stimulation: How AI enables new treatments for neurological diseases
Artificial intelligence is opening up new avenues in the treatment of neurological diseases. It promises not only faster diagnosis, but...
Read moreDetails
Why older people with heart disease often receive inadequate care
The ageing population brings with it a challenge: More and more people are affected by cardiovascular disease in old age....
Read moreDetails